These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

837 related articles for article (PubMed ID: 27855654)

  • 21. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
    Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
    J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
    Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM
    Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tubeimoside-1 inhibits the growth and invasion of colorectal cancer cells through the Wnt/β-catenin signaling pathway.
    Bian Q; Liu P; Gu J; Song B
    Int J Clin Exp Pathol; 2015; 8(10):12517-24. PubMed ID: 26722439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative profiling between primary colorectal carcinomas and metastases identifies heterogeneity on drug resistance.
    Luo F; Li J; Wu S; Wu X; Chen M; Zhong X; Liu K
    Oncotarget; 2016 Sep; 7(39):63937-63949. PubMed ID: 27613840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells.
    Hsu HC; Liu YS; Tseng KC; Tan BC; Chen SJ; Chen HC
    Cell Signal; 2014 Nov; 26(11):2333-42. PubMed ID: 25025569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salinomycin nanocrystals for colorectal cancer treatment through inhibition of Wnt/β-catenin signaling.
    Wang Z; Feng T; Zhou L; Jiang D; Zhang Y; He G; Lin J; Huang P; Lu D
    Nanoscale; 2020 Oct; 12(38):19931-19938. PubMed ID: 32990713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salinomycin exerts anti-angiogenic and anti-tumorigenic activities by inhibiting vascular endothelial growth factor receptor 2-mediated angiogenesis.
    Li T; Liu X; Shen Q; Yang W; Huo Z; Liu Q; Jiao H; Chen J
    Oncotarget; 2016 May; 7(18):26580-92. PubMed ID: 27058891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ARHGAP25: A negative regulator of colorectal cancer (CRC) metastasis via the Wnt/β-catenin pathway.
    Tao L; Zhu Y; Gu Y; Zheng J; Yang J
    Eur J Pharmacol; 2019 Sep; 858():172476. PubMed ID: 31228451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salinomycin exerts anti-colorectal cancer activity by targeting the β-catenin/T-cell factor complex.
    Wang Z; Zhou L; Xiong Y; Yu S; Li H; Fan J; Li F; Su Z; Song J; Sun Q; Liu SS; Xia Y; Zhao L; Li S; Guo F; Huang P; Carson DA; Lu D
    Br J Pharmacol; 2019 Sep; 176(17):3390-3406. PubMed ID: 31236922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymol Isolated from
    Zeng Q; Che Y; Zhang Y; Chen M; Guo Q; Zhang W
    Drug Des Devel Ther; 2020; 14():2535-2547. PubMed ID: 32669835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nerigoside suppresses colorectal cancer cell growth and metastatic potential through inhibition of ERK/GSK3β/β-catenin signaling pathway.
    Wen SY; Chen YY; Deng CM; Zhang CQ; Jiang MM
    Phytomedicine; 2019 Apr; 57():352-363. PubMed ID: 30831484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EGFL6 promotes cell proliferation in colorectal cancer via regulation of the WNT/β-catenin pathway.
    Zhang QW; Zhang XT; Tang CT; Lin XL; Ge ZZ; Li XB
    Mol Carcinog; 2019 Jun; 58(6):967-979. PubMed ID: 30693973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chlorquinaldol targets the β-catenin and T-cell factor 4 complex and exerts anti-colorectal cancer activity.
    Wang L; Deng K; Gong L; Zhou L; Sayed S; Li H; Sun Q; Su Z; Wang Z; Liu S; Zhu H; Song J; Lu D
    Pharmacol Res; 2020 Sep; 159():104955. PubMed ID: 32485279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.
    He F; Chen H; Yang P; Wu Q; Zhang T; Wang C; Wei J; Chen Z; Hu H; Li W; Cao J
    Oncotarget; 2016 Dec; 7(49):81156-81171. PubMed ID: 27835604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KY1022, a small molecule destabilizing Ras via targeting the Wnt/β-catenin pathway, inhibits development of metastatic colorectal cancer.
    Cho YH; Cha PH; Kaduwal S; Park JC; Lee SK; Yoon JS; Shin W; Kim H; Ro EJ; Koo KH; Park KS; Han G; Choi KY
    Oncotarget; 2016 Dec; 7(49):81727-81740. PubMed ID: 27835580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bisleuconothine A, a bisindole alkaloid, inhibits colorectal cancer cell in vitro and in vivo targeting Wnt signaling.
    Kong LM; Feng T; Wang YY; Li XY; Ye ZN; An T; Qing C; Luo XD; Li Y
    Oncotarget; 2016 Mar; 7(9):10203-14. PubMed ID: 26862734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toosendanin-induced apoptosis in colorectal cancer cells is associated with the κ-opioid receptor/β-catenin signaling axis.
    Wang H; Wen C; Chen S; Wang F; He L; Li W; Zhou Q; Yu WK; Huang L; Chen J; Liu R; Li W; Yang X; Liu H
    Biochem Pharmacol; 2020 Jul; 177():114014. PubMed ID: 32387457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
    Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
    Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone demethylase JMJD1A promotes colorectal cancer growth and metastasis by enhancing Wnt/β-catenin signaling.
    Peng K; Su G; Ji J; Yang X; Miao M; Mo P; Li M; Xu J; Li W; Yu C
    J Biol Chem; 2018 Jul; 293(27):10606-10619. PubMed ID: 29802196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cetuximab inhibits colorectal cancer development through inactivating the Wnt/β-catenin pathway and modulating PLCB3 expression.
    Zhang X; Zhou W; Wu C; Jiang J; Guo Q; Feng L; Cheng X; Zhang X
    Sci Rep; 2024 May; 14(1):10642. PubMed ID: 38724565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.